FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 106 filers reported holding FULCRUM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,269,895 | -16.8% | 1,899,968 | -28.1% | 0.02% | -17.4% |
| Q1 2023 | $7,534,465 | -37.7% | 2,643,672 | +77.0% | 0.02% | -52.1% |
| Q3 2022 | $12,086,000 | +24.0% | 1,494,003 | -24.9% | 0.05% | +17.1% |
| Q2 2022 | $9,745,000 | +26.8% | 1,988,800 | +511.9% | 0.04% | +32.3% |
| Q1 2022 | $7,686,000 | -14.1% | 325,000 | -35.7% | 0.03% | -13.9% |
| Q4 2021 | $8,945,000 | +126.5% | 505,655 | +261.2% | 0.04% | +111.8% |
| Q3 2021 | $3,949,000 | -31.8% | 140,000 | -74.7% | 0.02% | -34.6% |
| Q2 2021 | $5,794,000 | -14.5% | 552,885 | -3.9% | 0.03% | -18.8% |
| Q1 2021 | $6,776,000 | -56.8% | 575,246 | -57.0% | 0.03% | -57.9% |
| Q4 2020 | $15,669,000 | +30.9% | 1,338,123 | -11.4% | 0.08% | +24.6% |
| Q3 2020 | $11,974,000 | +151.1% | 1,510,000 | +479.2% | 0.06% | +96.8% |
| Q2 2020 | $4,768,000 | – | 260,697 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 2,343,154 | $10,403,604 | 3.92% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,718,881 | $25,391,832 | 1.37% |
| COWEN AND COMPANY, LLC | 4,308,359 | $19,129,113 | 1.34% |
| RA Capital Management | 11,609,704 | $51,547,086 | 1.02% |
| RTW INVESTMENTS, LP | 5,818,804 | $25,835,490 | 0.54% |
| Acuitas Investments, LLC | 134,811 | $598,561 | 0.35% |
| Simplify Asset Management Inc. | 570,519 | $2,533,104 | 0.29% |
| Vivo Capital, LLC | 520,000 | $2,308,800 | 0.25% |
| BRANDYWINE MANAGERS, LLC | 26,127 | $116,004 | 0.20% |
| DENALI ADVISORS LLC | 70,600 | $313,464 | 0.11% |